CytomX Therapeutics Inc (CTMX) financials · rev $11.7M
CytomX Therapeutics Inc (CTMX) rev $11.7M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $76.2M | $138.1M |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $0 | $0 |
| Operating Income | -$22.4M | $25.0M |
| Net Income | -$17.4M | $31.9M |
| EPS (Diluted) | $0.00 | $0.00 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $151.6M | $120.5M |
| Current Assets | $143.9M | $107.3M |
| Cash & Equivalents | $12.7M | $38.1M |
| Inventory | $0 | $0 |
| PP&E | $1.3M | $2.5M |
| Total Liabilities | $52.6M | $121.0M |
| Current Liabilities | $46.6M | $85.8M |
| Short-term Debt | $0 | $0 |
| Long-term Debt | $0 | $0 |
| Total Debt | $0 | $0 |
| Shareholders' Equity | $99.0M | -$456.0K |
| Retained Earnings | -$711.9M | -$691.6M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$75.6M | -$86.2M |
| CapEx | $220.0K | $310.0K |
| Investing Cash Flow | -$59.7M | $99.7M |
| Financing Cash Flow | $110.4M | $7.5M |
| Dividends Paid | $0 | $0 |
| Net Change in Cash | $0 | $0 |
| Free Cash Flow | -$75.8M | -$86.5M |
FAQ
What is CTMX P/E and revenue?
CytomX Therapeutics Inc (CTMX) rev $11.7M.
What is CTMX revenue?
CytomX Therapeutics Inc last cached revenue is $76.2M (FY2025).
Is CTMX profitable?
CytomX Therapeutics Inc last cached net income is -$17.4M.
What are CTMX total assets?
CytomX Therapeutics Inc last cached total assets are $151.6M.
What is CTMX free cash flow?
CytomX Therapeutics Inc last cached free cash flow is -$75.8M.
Not investment advice. Cached statements, not a live tape.